Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extracorporeal membrane oxygenation: a ten-year experience.

G Mols1, T Loop, K Geiger

  • 1Department of Anesthesiology and Critical Care Medicine, University of Freiburg, Freiburg, Germany.

American Journal of Surgery
|October 25, 2000
PubMed
Summary

Extracorporeal membrane oxygenation (ECMO) offers a therapeutic option for severe acute respiratory distress syndrome (ARDS), with a survival rate of 55% in treated patients. While not definitively proven by randomized trials, ECMO remains a valuable intervention for selected ARDS cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

German guidelines for airway management 2023.

Die Anaesthesiologie·2024
Same author

Exploring HIV disease indicators at MDR-TB treatment initiation in South Africa.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024
Same author

[Erratum to: Interdisciplinary COVID board for patients with triggered hyperferritinemic Inflammation].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2020
Same author

[Interdisciplinary COVID board for patients with SARS-CoV-2-triggered hyperferritinemic Inflammation].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2020
Same author

[Pro: thoracic epidural anesthesia in video-assisted thoracoscopy].

Der Anaesthesist·2020
Same author

[Daptomycin-induced eosinophilic pneumonia associated with an early endoprosthesis infection].

Der Anaesthesist·2020

Area of Science:

  • Critical Care Medicine
  • Respiratory Medicine
  • Cardiopulmonary Support

Background:

  • Severe acute respiratory distress syndrome (ARDS) necessitates advanced supportive therapies.
  • Extracorporeal membrane oxygenation (ECMO) serves as a vital supportive measure for critical ARDS cases.

Purpose of the Study:

  • To evaluate the outcomes, clinical parameters, and complications associated with ECMO in a cohort of ARDS patients.
  • To compare the survival rates between ARDS patients treated with and without ECMO.

Main Methods:

  • Prospective data collection of 245 ARDS patients from 1991 to 1999.
  • Comparative analysis of clinical parameters and outcomes for patients receiving ECMO versus those not on ECMO.

Main Results:

Related Experiment Videos

  • A total of 62 out of 245 ARDS patients (approximately 25%) received ECMO.
  • The survival rate for ECMO patients was 55%, compared to 61% for non-ECMO patients.
  • Patient referral status (in-house vs. external) was also documented.

Conclusions:

  • ECMO is a viable therapeutic option for severe ARDS, potentially improving survival rates.
  • A definitive randomized controlled trial is still needed to conclusively establish ECMO's benefit in ARDS.
  • ECMO should be considered for carefully selected ARDS patients in the absence of superior alternative therapies.